Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemochromatosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03356548
What this trial is testing

Transferrin Saturation and Asthenia in Hemochromatosis

Who this might be right for
Hemochromatoses, Genetic
Rennes University Hospital 260
Large-scale testing (Phase 3)Ended earlyNCT00122980
What this trial is testing

Stroke With Transfusions Changing to Hydroxyurea

Who this might be right for
HemochromatosisCerebrovascular AccidentAnemia, Sickle Cell+1 more
St. Jude Children's Research Hospital 134
Not applicableLooking for participantsNCT03131427
What this trial is testing

China Registry for Genetic / Metabolic Liver Diseases

Who this might be right for
Genetic/Metabolic Liver Diseases
Beijing Friendship Hospital 20,000
Not applicableWithdrawnNCT01991925
What this trial is testing

Implications for Quality of Life and Quality of Care in Patients With Hereditary Haemochromatosis

Who this might be right for
Hereditary Haemochromatosis
Universitaire Ziekenhuizen KU Leuven
Testing effectiveness (Phase 2)Looking for participantsNCT07371793
What this trial is testing

Evaluate BBI-001 in Healthy Volunteers and in Patients With Hereditary Hemochromatosis

Who this might be right for
Hereditary Hemochromatosis
Bond Biosciences 34
Large-scale testing (Phase 3)Study completedNCT00190385
What this trial is testing

Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis

Who this might be right for
Compensated Cirrhosis
Assistance Publique - Hôpitaux de Paris 1,200
Not applicableStudy completedNCT01784939
What this trial is testing

HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis

Who this might be right for
Hereditary Hemochromatosis C282Y Homozygous
Rennes University Hospital 31
Post-approval studies (Phase 4)Study completedNCT00733811
What this trial is testing

Efficacy Study of the Use of Sequential DFP-DFO Versus DFP

Who this might be right for
Beta-ThalassemiaThalassemia Major
Azienda Ospedaliera V. Cervello 213
Not applicableStudy completedNCT03990181
What this trial is testing

Inhibiting Dietary Iron Absorption in Subjects With Hereditary Hemochromatosis by a Natural Polyphenol Supplement

Who this might be right for
Iron Metabolism DisordersIron OverloadPolyphenols
Swiss Federal Institute of Technology 14
Large-scale testing (Phase 3)UnknownNCT01398644
What this trial is testing

Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients

Who this might be right for
Hereditary Hemochromatosis
Sanquin Research & Blood Bank Divisions 40
Large-scale testing (Phase 3)Ended earlyNCT00981370
What this trial is testing

Clinical Importance of Treating Iron Overload in Sickle Cell Disease

Who this might be right for
Anemia, Sickle CellTransfusion Hemosiderosis
Children's Hospital Los Angeles 1
Testing effectiveness (Phase 2)Ended earlyNCT02263638
What this trial is testing

Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study

Who this might be right for
Refractory Hemochromatosis Rheumatism
Rennes University Hospital 17
Large-scale testing (Phase 3)Study completedNCT00202436
What this trial is testing

Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy

Who this might be right for
Hemochromatosis
Sanquin Research & Blood Bank Divisions 40
Testing effectiveness (Phase 2)Looking for participantsNCT05937191
What this trial is testing

Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children

Who this might be right for
Idiopathic Pulmonary HemosiderosisLeflunomide
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 34
Testing effectiveness (Phase 2)Study completedNCT00631163
What this trial is testing

Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis

Who this might be right for
Chronic AnemiaTransfusional Hemosiderosis
Novartis Pharmaceuticals 102
Testing effectiveness (Phase 2)WithdrawnNCT01892644
What this trial is testing

Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome

Who this might be right for
HemochromatosisMyelodysplastic Syndromes
Haukeland University Hospital
Testing effectiveness (Phase 2)Study completedNCT00303329
What this trial is testing

Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients

Who this might be right for
AnemiaHemosiderosis
Novartis Pharmaceuticals 184
Not applicableStudy completedNCT04006249
What this trial is testing

Haemochromatosis and Periodontitis

Who this might be right for
Hemochromatosis
Rennes University Hospital 87
Large-scale testing (Phase 3)Study completedNCT00440986
What this trial is testing

Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis

Who this might be right for
Hereditary Hemochromatosis
San Filippo Neri General Hospital 25
Not applicableLooking for participantsNCT07028112
What this trial is testing

Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.

Who this might be right for
Iron OverloadHemosiderosisLiver Diseases+1 more
Assistance Publique - Hôpitaux de Paris 500
Next Page